Mackenzie Financial Corp Increases Holdings in Avanos Medical, Inc. (NYSE:AVNS)

Mackenzie Financial Corp grew its holdings in Avanos Medical, Inc. (NYSE:AVNS) by 51.2% in the 2nd quarter, according to the company in its most recent filing with the SEC. The firm owned 25,922 shares of the company’s stock after buying an additional 8,775 shares during the quarter. Mackenzie Financial Corp owned approximately 0.06% of Avanos Medical worth $516,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Canada Pension Plan Investment Board bought a new stake in shares of Avanos Medical during the 2nd quarter valued at about $70,000. EntryPoint Capital LLC lifted its holdings in Avanos Medical by 97.6% in the first quarter. EntryPoint Capital LLC now owns 5,601 shares of the company’s stock worth $112,000 after buying an additional 2,766 shares during the period. XTX Topco Ltd bought a new stake in Avanos Medical during the 2nd quarter valued at approximately $202,000. Magnetar Financial LLC bought a new stake in Avanos Medical during the 2nd quarter valued at approximately $248,000. Finally, Janney Montgomery Scott LLC grew its holdings in shares of Avanos Medical by 19.1% during the 1st quarter. Janney Montgomery Scott LLC now owns 13,010 shares of the company’s stock worth $259,000 after acquiring an additional 2,082 shares during the period. 95.17% of the stock is currently owned by institutional investors.

Avanos Medical Trading Up 0.8 %

AVNS opened at $23.21 on Friday. The company has a quick ratio of 1.49, a current ratio of 2.28 and a debt-to-equity ratio of 0.13. Avanos Medical, Inc. has a 52 week low of $17.24 and a 52 week high of $25.36. The stock has a market cap of $1.07 billion, a PE ratio of -17.45 and a beta of 0.91. The business has a 50 day moving average of $23.55 and a 200-day moving average of $21.14.

Avanos Medical (NYSE:AVNS) last announced its earnings results on Wednesday, July 31st. The company reported $0.34 EPS for the quarter, beating analysts’ consensus estimates of $0.29 by $0.05. The firm had revenue of $171.70 million for the quarter, compared to analysts’ expectations of $170.67 million. Avanos Medical had a net margin of 1.13% and a return on equity of 4.48%. The company’s quarterly revenue was up 1.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.24 EPS. Equities research analysts predict that Avanos Medical, Inc. will post 1.39 earnings per share for the current fiscal year.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.